Phencyclidine (PCP) Rapid Test

Phencyclidine, commonly abbreviated as PCP, is a mind-altering drug that affects the central nervous system. In drug screening, PCP is important because it may be associated with unsafe behavior, impaired coordination, altered perception, confusion, and other harmful effects. The Phencyclidine PCP Rapid Test helps professional users screen urine samples quickly and decide whether confirmatory testing is needed.

• The PCP rapid test is important for professional drug of abuse screening because PCP can cause unpredictable effects and may present safety concerns in workplace, rehabilitation, clinical, and forensic settings.
• The LARKSOIS Pharma Phencyclidine PCP Rapid Test may be used in workplace drug screening, rehabilitation monitoring, clinical toxicology, hospitals, diagnostic laboratories, forensic screening, correctional testing, and international diagnostic distribution.
• The PCP urine rapid test supports fast preliminary screening and helps identify samples that may require further laboratory evaluation.

The Phencyclidine (PCP) Rapid Test by LARKSOIS Pharma may be used in professional diagnostic and institutional screening environments.

Applications

• Workplace and pre-employment drug screening
• Rehabilitation and de-addiction monitoring
• Clinical toxicology screening
• Hospitals and diagnostic laboratories
• Forensic and legal screening support
• Correctional or institutional screening programs
• International diagnostic distribution
• Laboratory and professional screening workflows

• The Phencyclidine PCP Rapid Test generally works through a rapid immunoassay format. A urine specimen is collected in a clean container, the test is performed according to the product insert, and results are read within the specified time window.
• The 25 ng/mL cut-off means the test is designed to screen for PCP at or above the stated threshold.
• A result from the PCP rapid test kit should always be interpreted according to the product insert, and any non-negative or disputed result should be confirmed through a definitive laboratory method.

The Phencyclidine (PCP) Rapid Test uses a rapid urine screening method for qualitative detection of PCP. It is designed to provide a preliminary screening result at the stated 25 ng/mL cut-off.

Benefits

• Urine-based PCP screening
• 25 ng/mL cut-off for professional screening needs
• Fast qualitative drug of abuse screening
• Simple rapid test method
• Suitable for laboratories and field screening programs
• Useful for workplace, rehabilitation, clinical, and forensic testing
• Supports international diagnostic supply
• Helps identify samples that may need confirmatory testing

The Phencyclidine (PCP) Rapid Test is designed for urine specimens. Urine is widely used in drug screening because it is practical, non-invasive, and suitable for professional toxicology screening workflows.

Guidance

• Use urine specimens only
• Use a clean urine specimen container
• Follow the product insert exactly
• Read results within the stated time window
• Do not reuse the test device
• Record test details correctly
• Treat all urine samples as potentially biohazardous
• Send non-negative or disputed results for confirmation when required

Note

A rapid screening result should be considered preliminary unless confirmed by a validated laboratory method where required.

The Phencyclidine (PCP) Rapid Test by LARKSOIS Pharma has a stated cut-off of 25 ng/mL. This means the test is designed to screen urine specimens for PCP at or above the validated threshold. LARKSOIS Pharma should mention the exact performance details according to the final product insert, technical file, and regulatory documentation.

The PCP urine test is a screening product, not a final diagnostic result. A negative result does not always mean no PCP is present; the level may be below the test cut-off or outside the detection window. A non-negative result does not prove impairment, addiction, misuse, or exact timing of drug use.

Instructions

• A positive result is preliminary only
• A negative result does not always rule out exposure
• Drug levels may be below the cut-off concentration
• Specimen quality may affect the result
• Medication or metabolite cross-reactivity may occur
• Testing method differences may affect interpretation
• Confirmatory testing is recommended for important results

Instructions

• Urine-based PCP screening
• 25 ng/mL cut-off for professional screening needs
• Fast qualitative drug of abuse screening
• Simple rapid test method
• Suitable for laboratories and field screening programs
• Useful for workplace, rehabilitation, clinical, and forensic testing
• Supports international diagnostic supply
• Helps identify samples that may need confirmatory testing

Note

The Phencyclidine PCP Rapid Test by LARKSOIS Pharma is developed for professional users who need a practical, easy-to-use, and internationally suitable PCP screening solution.

Steps

• Bring the test device and urine specimen to the recommended testing condition
• Open the sealed pouch only when ready to test
• Collect urine using a clean sample collection procedure
• Apply the urine specimen according to the product insert
• Wait for the test reaction to complete within the instructed time
• Read the result within the approved interpretation window
• Dispose of used materials according to laboratory safety rules

Note

The exact procedure must follow the official LARKSOIS Pharma product insert supplied with the Phencyclidine (PCP) Rapid Test.

Positive

A positive or non-negative result suggests that PCP may be present in the urine specimen at or above the stated cut-off. Positive results are preliminary and should be confirmed using a recognized laboratory method where required.

Negative

A negative result suggests that PCP was not detected or was below the cut-off at the time of testing. A negative result does not always rule out exposure if sample quality, collection timing, or the detection window affects the result.

Invalid

If the valid control indicator does not appear, the test is invalid. The test should be repeated with a new device and fresh urine specimen according to the product insert.

Instructions

• Store according to the product label and package insert
• Keep the test device sealed until use
• Protect from moisture and direct sunlight
• Avoid using expired or damaged tests
• Use a clean urine specimen container
• Read results within the stated time window
• Do not reuse the test device

Instructions

• For professional screening use only
• Use urine specimen only as directed
• Do not reuse the test device
• Follow the product insert carefully
• Handle all urine specimens as potentially infectious material
• Do not interpret results after the recommended reading time
• Confirm presumptive positive results with laboratory testing
• Follow applicable drug testing laws and reporting requirements

LARKSOIS Pharma provides international-quality pharmaceutical and diagnostic products for global healthcare and screening markets. The Phencyclidine PCP Rapid Test is suitable for distributors, laboratories, hospitals, rehabilitation centers, workplace testing providers, and toxicology screening programs.

Advantages

• International diagnostic product focus
• Reliable rapid testing solutions
• Suitable for laboratories and healthcare suppliers
• Distributor-friendly product format
• Supports drug of abuse screening programs
• Designed for practical urine screening workflows
• Quality-focused standards under LARKSOIS Pharma